THERAVECTYS
THERAVECTYS develops a platform for the PREvention and treatment of cancers and other infectious diseases and conditions.
Total raised
€24M
€24,080,000
Funding rounds
3
Investors
2
distinct backers
Active since
2012-08
latest 2014-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood9
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-01-01 | Other | €1.9M | Bpifrance | View deal → |
| 2013-10-01 | Other | €15M | — | View deal → |
| 2012-09-01 | Other | €7.5M | John PIETERS | View deal → |
Investors
2Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software